Related Experiment Video
Updated: Jun 5, 2026
Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens
Published on: May 23, 2014
Dysregulation of betaglycan expression in primary human endometrial carcinomas
Piotr K Zakrzewski1, Jacek Mokrosinski, Adam I Cygankiewicz
1Department of Cytobiochemistry, Medical University of Lublin, Lublin, Poland.
Abstract:
TGFβ signaling cascade plays a vital role in neoplastic transformation, but the function of betaglycan, which is a TGFβ accessory receptor, is still unknown in particular cancer. Evaluation of betaglycan expression both at mRNA (real-time PCR) and protein (ELISA) level in the context of TGFβ canonical signaling components, i.e., TGFβ1, TGFβ2, and TGFβRII, in endometrial carcinomas was performed. Betaglycan mRNA expression level was significantly (p < .001) downregulated with simultaneous betaglycan protein level upregulation in cancer samples. Obtained results suggest that endometrial cancer is associated with disruption of accessory receptor betaglycan expression, what may alter TGFβ2-induced signaling.
Insights
Betaglycan expression is altered in endometrial cancer, with decreased mRNA and increased protein levels. This disruption may impact transforming growth factor beta 2 (TGFβ2) signaling in cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Transforming growth factor beta (TGFβ) signaling is crucial in cancer development.
- The role of betaglycan, a TGFβ accessory receptor, in endometrial cancer remains unclear.
Purpose of the Study:
- To investigate betaglycan expression at mRNA and protein levels in endometrial carcinomas.
- To analyze betaglycan expression in relation to TGFβ1, TGFβ2, and TGFβRII.
Main Methods:
- Real-time PCR was used to quantify betaglycan mRNA levels.
- Enzyme-linked immunosorbent assay (ELISA) was employed to measure betaglycan protein levels.
Main Results:
- Betaglycan mRNA expression was significantly downregulated in endometrial cancer tissues (p < .001).
- Conversely, betaglycan protein levels were upregulated in cancer samples.
- These findings indicate a disruption in betaglycan expression patterns.
Conclusions:
- Endometrial cancer is associated with dysregulated betaglycan expression.
- Altered betaglycan expression may modify TGFβ2-induced signaling pathways.
- Further research is warranted to understand the functional implications of these changes.
